A recent letter to the NEJM gives some pause on Advair. The problem is with the salmeterol component, which can lead to clinical worsening if given during an acute asthma attack.
More warnings on Advair
ADVERTISEMENT
More in Uncategorized
Past Week
-
The mental health workforce is collapsing
-
A doctor’s struggle with burnout and boundaries
-
The stoic cure for modern anxiety
-
How AI is transforming health care with real-world data insights [PODCAST]
-
Global surgery needs advocates, not just evidence
-
A mother’s question about PCOS and her son’s autism
-
Past 6 Months
-
Rethinking the JUPITER trial and statin safety
-
The ignored clinical trials on statins and mortality
-
How one physician redesigned her practice to find joy in primary care again [PODCAST]
-
Why doctors must fight for a just health care system
-
I passed my medical boards at 63. And no, I was not having a midlife crisis.
-
How the internet broke the doctor-parent trust
-
Recent Posts
-
Global surgery needs advocates, not just evidence
-
The hypocrisy of insurance referral mandates
-
The timeless art of diagnostic reasoning
-
Why health self-advocacy is an essential life skill
-
How functional medicine helps where conventional care falls short [PODCAST]
-
What MS can teach cardiologists about disease
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
